株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

3D医用画像の世界市場:将来予測

Global 3D Medical Imaging Market Forecast 2020-2028

発行 Inkwood Research 商品コード 675315
出版日 ページ情報 英文 328 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。
Back to Top
3D医用画像の世界市場:将来予測 Global 3D Medical Imaging Market Forecast 2020-2028
出版日: 2019年12月23日 ページ情報: 英文 328 Pages
概要

当レポートでは、世界の3D医用画像 (メディカルイメージング) の将来展望について分析し、技術の概略や市場の基本構造、主な促進・抑制要因、市場全体およびコンポーネント別・展開方式別・エンドユーザー別・用途別・地域別の市場動向見通し (今後9年間分)、主要企業のプロファイルなどを調査しております。

第1章 分析範囲・手法

第2章 エグゼクティブサマリー

第3章 市場のダイナミクス

  • 市場の定義
  • 主な市場促進要因
  • 主な市場抑制要因

第4章 主な分析指標

  • ポーターのファイブフォース分析
  • サプライチェーン分析
    • サプライヤー
    • 研究開発 (R&D)
    • 製造
    • エンドユーザー
  • 3D医療業界におけるイノベーション
  • 規制体制:北米、欧州、アジア太平洋地域
  • 市場機会マトリックス
  • ベンダー環境
  • 主要投資の分析

第5章 コンポーネント別の市場

  • ハードウェア
  • ソフトウェア
  • サービス

第6章 展開方式別の市場

  • Webベース・プラットフォーム
  • クラウドベース・プラットフォーム
  • オンプレミスベース・プラットフォーム

第7章 エンドユーザー別の市場

  • 病院
  • 診断センター
  • 救急医療サービス
  • 研究センター

第8章 用途別の市場

  • 超音波
  • デジタルX線画像 (DR)
  • MRI (核磁気共鳴画像)
  • CT (コンピューター断層撮影)
  • 核イメージング
  • マンモグラフィー
  • 内視鏡
  • その他

第9章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (ドイツ、英国、フランス、イタリア、ロシア、ベルギー、ポーランドなど)
  • アジア太平洋地域 (中国、インド、日本、オーストラリア・ニュージーランド、韓国、タイ、インドネシア、ベトナムなど)
  • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第10章 企業プロファイル

  • AMBRA HEALTH
  • ARTERYS
  • DEPUY SYNTHES
  • FOVIA
  • GE HEALTHCARE
  • KONINKLIJKE PHILIPS N.V.
  • MACH7 TECHNOLOGIES LTD.
  • MEDTRONIC INC.
  • オリンパス
  • PIE MEDICAL IMAGING BV
  • PLANMECA OY
  • SIEMENS HEALTHCARE
  • STRYKER CORPORATION
  • SURGICAL THEATER, LLC
  • WHITECLOUDS
図表

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - 3D MEDICAL IMAGING
  • TABLE 2: ROBOTICS ASSISTED MINIMALLY INVASIVE SURGERIES
  • TABLE 3: NON-ROBOTIC ASSISTED MINIMALLY INVASIVE SURGERIES
  • TABLE 4: BENEFITS OF 3D IMAGING TECHNIQUES
  • TABLE 5: GERIATRIC POPULATION ACROSS DIFFERENT REGION (60 YEARS & ABOVE)
  • TABLE 6: COMPONENTS OF 3D MEDICAL IMAGING INSTRUMENTS
  • TABLE 7: MANDATORY REGULATORY GUIDELINES FOR SUPPLIERS AND MANUFACTURERS
  • TABLE 8: 3D MEDICAL INNOVATIONS
  • TABLE 9: MEDICAL SOFTWARE CLASSIFICATION
  • TABLE 10: GLOBAL 3D MEDICAL IMAGING, BY COMPONENT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: GLOBAL 3D MEDICAL IMAGING, BY COMPONENT, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL HARDWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: GLOBAL HARDWARE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL SOFTWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: GLOBAL SOFTWARE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 16: 3D MEDICAL AND SURGICAL IMAGING SERVICES
  • TABLE 17: GLOBAL SERVICE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 18: GLOBAL SERVICE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 19: GLOBAL 3D MEDICAL IMAGING, BY DEPLOYMENT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 20: GLOBAL 3D MEDICAL IMAGING, BY DEPLOYMENT, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 21: ADVANTAGES AND DISADVANTAGES OF WEB BASED 3D MEDICAL IMAGING PLATFORMS
  • TABLE 22: GLOBAL WEB BASED PLATFORM MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: GLOBAL WEB BASED PLATFORM MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL CLOUD-BASED PLATFORM MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: GLOBAL CLOUD BASED PLATFORM MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL ON-PREMISE BASED PLATFORM MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: GLOBAL ON-PREMISE BASED PLATFORM MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 28: ADVANTAGES AND DISADVANTAGES OF ON-PREMISE 3D MEDICAL IMAGING PLATFORMS
  • TABLE 29: GLOBAL 3D MEDICAL IMAGING, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 30: GLOBAL 3D MEDICAL IMAGING, BY END-USER, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 31: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 32: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 33: GLOBAL DIAGNOSTIC CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 34: GLOBAL DIAGNOSTIC CENTERS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 35: GLOBAL AMBULATORY AND HEALTHCARE SETTINGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 36: GLOBAL AMBULATORY AND HEALTHCARE SETTINGS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 37: GLOBAL RESEARCH CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 38: GLOBAL RESEARCH CENTERS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 39: GLOBAL 3D MEDICAL IMAGING, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 40: GLOBAL 3D MEDICAL IMAGING, BY APPLICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 41: GLOBAL ULTRASOUND MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 42: MAJOR USES OF ULTRASOUND
  • TABLE 43: GLOBAL ULTRASOUND MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL DIGITAL RADIOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 45: GLOBAL DIGITAL RADIOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL MAGNETIC RESONANCE IMAGING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 47: GLOBAL MAGNETIC RESONANCE IMAGING MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL COMPUTED TOMOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 49: GLOBAL COMPUTED TOMOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL NUCLEAR IMAGING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 51: GLOBAL NUCLEAR IMAGING MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL MAMMOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 53: GLOBAL MAMMOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL ENDOSCOPY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 55: GLOBAL ENDOSCOPY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 56: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 57: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 58: GLOBAL 3D MEDICAL IMAGING, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 59: GLOBAL 3D MEDICAL IMAGING, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 60: NORTH AMERICA 3D MEDICAL IMAGING, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 61: NORTH AMERICA 3D MEDICAL IMAGING, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 62: EUROPE 3D MEDICAL IMAGING, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 63: EUROPE 3D MEDICAL IMAGING, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 64: ASIA PACIFIC 3D MEDICAL IMAGING, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 65: ASIA PACIFIC 3D MEDICAL IMAGING, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
  • TABLE 66: REST OF WORLD 3D MEDICAL IMAGING, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 67: REST OF WORLD 3D MEDICAL IMAGING, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: NUMBER OF DEATHS DUE TO A CHRONIC DISEASE, 2005-2030 (MILLION)
  • FIGURE 2: RISING AGING POPULATION GLOBALLY, 2016-2022 (MILLION)
  • FIGURE 3: RISING HEALTHCARE SPENDING BY INSTITUTION, 2015-2040 ($ TRILLION)
  • FIGURE 4: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 5: 3D MEDICAL IMAGING INDUSTRY STRUCTURE
  • FIGURE 6: R&D IN MEDICAL TECHNOLOGY
  • FIGURE 7: R&D PHASE FROM CONCEPTUALIZATION TO DEVELOPMENT
  • FIGURE 8: MARKETING MATRIX FOR MEDICAL TECHNOLOGY PRODUCTS
  • FIGURE 9: MANUFACTURING PROCESS IN MEDICAL IMAGING INSTRUMENTS
  • FIGURE 10: OPPORTUNITY MATRIX
  • FIGURE 11: VENDOR LANDSCAPE
  • FIGURE 12: KEY INVESTMENT INSIGHTS
  • FIGURE 13: COST BREAK DOWN OF OWNING HYBRID OPERATING ROOM
  • FIGURE 14: GLOBAL 3D MEDICAL IMAGING, BY COMPONENT, IN 2019
  • FIGURE 15: GLOBAL 3D MEDICAL IMAGING MARKET, BY HARDWARE, 2020-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL 3D MEDICAL IMAGING MARKET, BY SOFTWARE, 2020-2028 (IN $ MILLION)
  • FIGURE 17: STRUCTURE OF SOFTWARE
  • FIGURE 18: GLOBAL 3D MEDICAL IMAGING MARKET, BY SERVICE, 2020-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL 3D MEDICAL IMAGING, BY DEPLOYMENT, IN 2019
  • FIGURE 20: GLOBAL 3D MEDICAL IMAGING MARKET, BY WEB BASED PLATFORM, 2020-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL 3D MEDICAL IMAGING MARKET, BY CLOUD-BASED PLATFORM, 2020-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL 3D MEDICAL IMAGING MARKET, BY ON-PREMISE BASED PLATFORM, 2020-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL 3D MEDICAL IMAGING, BY END-USER, IN 2019
  • FIGURE 24: GLOBAL 3D MEDICAL IMAGING MARKET, BY HOSPITALS, 2020-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL 3D MEDICAL IMAGING MARKET, BY DIAGNOSTIC CENTERS, 2020-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL 3D MEDICAL IMAGING MARKET, BY AMBULATORY AND HEALTHCARE SETTINGS, 2020-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL 3D MEDICAL IMAGING MARKET, BY RESEARCH CENTERS, 2020-2028 (IN $ MILLION)
  • FIGURE 28: GLOBAL 3D MEDICAL IMAGING, BY APPLICATION, IN 2019
  • FIGURE 29: GLOBAL 3D MEDICAL IMAGING MARKET, BY ULTRASOUND, 2020-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL 3D MEDICAL IMAGING MARKET, BY DIGITAL RADIOGRAPHY, 2020-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL 3D MEDICAL IMAGING MARKET, BY MAGNETIC RESONANCE IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 32: GLOBAL 3D MEDICAL IMAGING MARKET, BY COMPUTED TOMOGRAPHY, 2020-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL 3D MEDICAL IMAGING MARKET, BY NUCLEAR IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 34: APPLICATION OF 3D MEDICAL IMAGING PLATFORMS IN NUCLEAR IMAGING
  • FIGURE 35: GLOBAL 3D MEDICAL IMAGING MARKET, BY MAMMOGRAPHY, 2020-2028 (IN $ MILLION)
  • FIGURE 36: FACTORS AFFECTING BREAST CANCER RISK IN WOMEN
  • FIGURE 37: GLOBAL 3D MEDICAL IMAGING MARKET, BY ENDOSCOPY, 2020-2028 (IN $ MILLION)
  • FIGURE 38: GLOBAL 3D MEDICAL IMAGING MARKET, BY OTHER APPLICATIONS, 2020-2028 (IN $ MILLION)
  • FIGURE 39: APPLICATIONS OF LAPAROSCOPY
  • FIGURE 40: NORTH AMERICA 3D MEDICAL IMAGING MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 41: THE UNITED STATES 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 42: CANADA 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 43: EUROPE 3D MEDICAL IMAGING MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 44: GERMANY 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 45: THE UNITED KINGDOM 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 46: FRANCE 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 47: ITALY 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 48: RUSSIA 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 49: BELGIUM 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 50: POLAND 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 51: REST OF EUROPE 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 52: ASIA PACIFIC 3D MEDICAL IMAGING MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 53: CHINA 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 54: INDIA 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 55: JAPAN 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 56: AGING POPULATION IN JAPAN 2010-2040 (%)
  • FIGURE 57: AUSTRALIA & NEW ZEALAND 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 58: SOUTH KOREA 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 59: THAILAND 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 60: INDONESIA 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 61: VIETNAM 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 62: REST OF ASIA PACIFIC 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 63: REST OF WORLD 3D MEDICAL IMAGING MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 64: LATIN AMERICA 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
  • FIGURE 65: MIDDLE EAST & AFRICA 3D MEDICAL IMAGING, 2020-2028 (IN $ MILLION)
目次
Product Code: 20406

KEY FINDINGS

The global market for 3D medical imaging is estimated to register a CAGR of 5.93% during the forecasted period, 2020-2028. The increasing healthcare expenditure, rising demand for automation technologies in healthcare, and the growing geriatric population, are some of the important factors boosting the global market growth.

MARKET INSIGHTS

3D medical imaging is an innovative technique utilized for creating 3D images of the body parts for timely and accurate diagnosis for further medical intervention. There is an increasing demand for 3D medical imaging as a result of its increasing applications in oncology and cardiology. The healthcare sector is witnessing the significant adoption of technology. These technologies include electronic health records, predictive analysis, precision surgeries, robotics, etc. The 3D medical imaging systems aid the physicians in the diagnosis of chronic diseases, along with performing surgeries. The systems are also used for the examination of bones, nervous systems, muscles, etc. Moreover, the global healthcare expenditure is estimated to increase.

There are regulatory frameworks and stringent labeling requirements laid down by the regulatory bodies for the 3D medical imaging equipment. They need to undergo a safety examination due to their high-risk nature. Since these processes take a great deal of time, it results in delayed product launch, affecting the revenue of vendors. Also, the high installation and maintenance costs impede the market growth.

REGIONAL INSIGHTS

The global 3D medical imaging market is geographically analyzed through the market regions of Europe, North America, Asia Pacific, and the Rest of the World. As of 2019, the North American region dominated the market with regard to revenue share, and is estimated to hold the largest market share by the end of the forecasted period. This is attributed to the rising number of surgeries due to increased chronic disease cases. The Asia Pacific region is projected to be the fastest-growing market region as a result of the developing healthcare infrastructure, rising healthcare expenditure, increasing old-age population, etc.

COMPETITIVE INSIGHTS

Some of the renowned companies in the market include, Depuy Synthes, Fovia, Arterys, Ambra Health, Ge Healthcare, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of contents

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. RISING ADOPTION OF MINIMALLY INVASIVE PROCEDURES
    • 3.2.2. GROWING DEMAND FOR AUTOMATION TECHNOLOGIES IN THE HEALTHCARE SECTOR
    • 3.2.3. SIGNIFICANT USAGE OF THE NEW VISUALIZATION METHODS AND TECHNOLOGY
    • 3.2.4. INCREASING PREVALENCE OF CHRONIC DISEASES
    • 3.2.5. GROWING AGING POPULATION
    • 3.2.6. GROWING HEALTHCARE EXPENDITURE
  • 3.3. KEY RESTRAINTS
    • 3.3.1. STRINGENT REGULATORY FRAMEWORK AND CLINICAL TRIALS
    • 3.3.2. HIGH INSTALLATION AND MAINTENANCE COSTS
    • 3.3.3. MARKET ENTRY BARRIERS FOR NEW COMPANIES

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. SUPPLY CHAIN ANALYSIS
    • 4.2.1. SUPPLIERS
    • 4.2.2. RESEARCH & DEVELOPMENT
    • 4.2.3. MANUFACTURING
    • 4.2.4. END USERS
  • 4.3. INNOVATIONS IN THE 3D MEDICAL INDUSTRY
  • 4.4. REGULATORY FRAMEWORK
    • 4.4.1. REGULATIONS IN NORTH AMERICA
    • 4.4.2. REGULATIONS IN EUROPE
    • 4.4.3. REGULATIONS IN ASIA PACIFIC
  • 4.5. OPPORTUNITY MATRIX
  • 4.6. VENDOR LANDSCAPE
  • 4.7. KEY INVESTMENT INSIGHTS

5. MARKET BY COMPONENT

  • 5.1. HARDWARE
  • 5.2. SOFTWARE
  • 5.3. SERVICE

6. MARKET BY DEPLOYMENT

  • 6.1. WEB-BASED PLATFORM
  • 6.2. CLOUD-BASED PLATFORM
  • 6.3. ON-PREMISE BASED PLATFORM

7. MARKET BY END-USER

  • 7.1. HOSPITALS
  • 7.2. DIAGNOSTIC CENTERS
  • 7.3. AMBULATORY AND HEALTHCARE SETTINGS
  • 7.4. RESEARCH CENTERS

8. MARKET BY APPLICATION

  • 8.1. ULTRASOUND
  • 8.2. DIGITAL RADIOGRAPHY
  • 8.3. MAGNETIC RESONANCE IMAGING
  • 8.4. COMPUTED TOMOGRAPHY
  • 8.5. NUCLEAR IMAGING
  • 8.6. MAMMOGRAPHY
  • 8.7. ENDOSCOPY
  • 8.8. OTHER APPLICATIONS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. GERMANY
    • 9.2.2. THE UNITED KINGDOM
    • 9.2.3. FRANCE
    • 9.2.4. ITALY
    • 9.2.5. RUSSIA
    • 9.2.6. BELGIUM
    • 9.2.7. POLAND
    • 9.2.8. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. CHINA
    • 9.3.2. INDIA
    • 9.3.3. JAPAN
    • 9.3.4. AUSTRALIA & NEW ZEALAND
    • 9.3.5. SOUTH KOREA
    • 9.3.6. THAILAND
    • 9.3.7. INDONESIA
    • 9.3.8. VIETNAM
    • 9.3.9. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST & AFRICA

10. COMPANY PROFILES

  • 10.1. AMBRA HEALTH
  • 10.2. ARTERYS
  • 10.3. DEPUY SYNTHES
  • 10.4. FOVIA
  • 10.5. GE HEALTHCARE
  • 10.6. KONINKLIJKE PHILIPS N.V.
  • 10.7. MACH7 TECHNOLOGIES LTD.
  • 10.8. MEDTRONIC INC.
  • 10.9. OLYMPUS CORPORATION
  • 10.10. PIE MEDICAL IMAGING BV
  • 10.11. PLANMECA OY
  • 10.12. SIEMENS HEALTHCARE
  • 10.13. STRYKER CORPORATION
  • 10.14. SURGICAL THEATER, LLC
  • 10.15. WHITECLOUDS
Back to Top